Komori
Jcu (4975) · InitiativeAdvanced

Postponement of plans to construct and renovate research institute facilities

First written in FY2021-Q2. 4 of 6 entries say "Advanced", first in FY2022. Latest entry: FY2026.

6entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2021-Q2 – FY2021-Q3AdvancedFY2022 – FY20262020: 12021: 120212022: 120222023: 120232024: 020242025: 120252026: 12026
Same theme, other companies
Deferral or postponement of research institute capital investment plansA theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「We also invested ¥1,028 million in acquiring land for our Research Institute in Asao-ku, Kawasaki City, ¥429 million in experimental equipment and measuring instruments, ¥208 million in land for relocating our Nagoya Branch in Kita-ku, Nagoya City, and ¥97 million in analytical equipment for our subsidiary JCU Surface Technology (Hubei) Co., Ltd.」

    At the Research Institute, we invested ¥1,028 million in land and ¥429 million in experimental equipment and measuring instruments, progressing the development of our research and development infrastructure.
  2. FY2025AdvancedAnnual report

    「We invested ¥426 million in experimental equipment and measuring instruments at our Research Institute in Asao-ku, Kawasaki City.」

    Investment in experimental equipment and measuring instruments at the Research Institute totaled ¥426 million, advancing the development of our research and development infrastructure.
  3. FY2023AdvancedAnnual report

    「We invested ¥157 million in experimental equipment and measuring instruments and ¥48 million in renewing air-conditioning equipment at our Research Institute in Asao-ku, Kawasaki City.」

    At the Research Institute, we invested a total of ¥205 million in experimental equipment, measuring instruments and air-conditioning equipment, progressing the development of our research and development infrastructure.
  4. FY2022AdvancedAnnual report

    「We invested ¥114 million in experimental equipment at our Research Institute in Asao-ku, Kawasaki City.」

    Separate from the research institute facilities that had been postponed or left undecided in the previous fiscal year, we invested in research and development-related facilities, including experimental equipment at the Research Institute, during the current consolidated fiscal year.
  5. FY2021-Q3RestatedAnnual report

    「The following major facility construction and renovation projects that were planned at the end of the previous consolidated fiscal year underwent significant changes or were completed during the nine months ended the third quarter of the current consolidated fiscal year.」

    The No. 3 PP pretreatment large line, No. 3 PP copper sulfate plating equipment, transmission X-ray equipment and renovation work for Laboratory No. 12, which were planned at the end of the previous consolidated fiscal year, continue to be listed as cancelled projects, with a total planned investment of ¥82 million and the timing of commencement and completion undecided.
  6. FY2021-Q2First statedAnnual report

    「The following major facility construction and renovation projects that were planned at the end of the previous consolidated fiscal year were postponed from implementation during the current consolidated fiscal year.」

    For the No. 3 PP pretreatment large line in Asao-ku, Kawasaki City (¥23 million), the No. 3 PP copper sulfate plating equipment (¥18 million), the transmission X-ray equipment (¥11 million), and renovation work for Laboratory No. 12 (¥30 million), implementation of the plans funded with internal resources was postponed, and the timing of commencement and completion remains undecided.
Moved together

"Earnings Base Centered on Overseas Pharmaceutical Sales" moved the same way as this thread, in the same document, in 4 of its 6 moves.

443333★123456
  1. ★This thread
  2. 1Earnings Base Centered on Overseas Pharmaceutical Sales4×
  3. 2Advancing Local Overseas Production and Diversifying Production and Supply Systems4×
  4. 3Balancing Stable Dividends with Retained Earnings and Business Investment3×
  5. 4Strengthening the Sales Network and Overseas Sales Operations Through Overseas Subsidiaries3×
  6. 5Zero CO2 Emissions at Niigata Plant3×
  7. 6Establishment of a semiconductor-related research and manufacturing site in Kumamoto Prefecture3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Jcu's next results are scheduled for 2026-11-05. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.